Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults
Clinical trial NCT02255760 · COMPLETED
Trial details
- NCT number
- NCT02255760
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-04
- Primary completion
- 2015-04-20
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.